Hepatitis study. Drug trial deaths deemed unavoidable.
Marshall
E
E
D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001086:Arabinofuranosyluracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic / Q000592:standards*; D035082:Federal Government; D033161:Government Regulation; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D009316:National Institutes of Health (U.S.); D010182:Pancreatic Diseases / Q000139:chemically induced; D035842:Research Subjects; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D001086:Arabinofuranosyluracil; C043457:fialuridine